Our pan-cancer meta-analysis based on The Cancer Genome Atlas (TCGA) data showed that PRDM12 was upregulated in several cancer types: colon, breast, kidney, colon, lung, liver, thyroid, ovary and prostate cancers, suggesting that it could represent a putative tumor marker [25]. The gene discussed is PRDM12; the disease is Familial prostate cancer.